ArticlePloS one2022

Long-term safety and efficacy of ferric citrate in phosphate-lowering and iron-repletion effects among patients with on hemodialysis: A multicenter, open-label, Phase IV trial.

Chien-Te Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.